Towards Healthcare
Precision Medicine Market Size Drives USD 118.52 Billion in 2025

Precision Medicine Market Trends 2025 Hospitals Lead Adoption as Genomics and Pharmacogenomics Reshape Healthcare

Projections indicate that, precision medicine industry is projected to rise from USD 101.86 billion in 2024 to USD 463.11 billion by 2034, reflecting a CAGR of 16.35% over the next decade. The market is growing due to increasing demand for personalized treatments tailored to individual genetic profiles. Advancements in genomics and data analytics are enabling more accurate diagnoses and targeted therapies.

Content

  • Insight Code: 5821
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The precision medicine market is projected to reach USD 463.11 billion by 2034, growing at a CAGR of 16.35% from 2024 to 2034.

North America is currently leading the healthcare cybersecurity market due to a strong focus on biomedical innovation, widespread use of advanced diagnostic tools, and increasing public-private collaborations.

The precision medicine market includes five segments by component, by product, by application, by technology, by end-user, and by region.

Some key players include Roche Diagnostics, Illumina, Inc., Thermo Fisher Scientific, QIAGEN N.V., and Agilent Technologies.

Key trends include the growth due to increasing demand for personalized treatments tailored to individual genetic profiles.

Traditional medicine often uses standard treatments for all patients with the same condition, while precision medicine uses genetic and molecular data to customize treatments based on individual differences.

Genetics helps identify mutations or variations in DNA that may cause or influence diseases. This information guides the selection of targeted therapies that are more likely to be effective for specific individuals.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions